Bempedoic acid 180 mg tablet
1002-043
Phase 3 small_molecule completed
Quick answer
Bempedoic acid 180 mg tablet for Cardiovascular Diseases is a Phase 3 program (small_molecule) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Cardiovascular Diseases
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed